Jpmorgan Chase & CO Tandem Diabetes Care Inc Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 392,586 shares of TNDM stock, worth $12.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
392,586
Previous 197,583 98.69%
Holding current value
$12.9 Million
Previous $8.38 Million 68.8%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$27.34 - $41.78 $5.33 Million - $8.15 Million
195,003 Added 98.69%
392,586 $14.1 Million
Q3 2024

Dec 26, 2024
BUY
$35.21 - $47.3 $3.99 Million - $5.36 Million
113,355 Added 134.58%
197,583 $8.38 Million
Q3 2024

Nov 08, 2024
BUY
$35.21 - $47.3 $3.99 Million - $5.36 Million
113,355 Added 134.58%
197,583 $8.38 Million
Q2 2024

Dec 26, 2024
SELL
$30.43 - $53.43 $3.45 Million - $6.06 Million
-113,355 Reduced 57.37%
84,228 $3.39 Million
Q2 2024

Aug 12, 2024
SELL
$30.43 - $53.43 $287,076 - $504,058
-9,434 Reduced 10.07%
84,228 $3.39 Million
Q1 2024

Dec 26, 2024
SELL
$22.09 - $35.41 $2.3 Million - $3.68 Million
-103,921 Reduced 52.6%
93,662 $3.32 Million
Q1 2024

May 10, 2024
BUY
$22.09 - $35.41 $159,865 - $256,262
7,237 Added 8.37%
93,662 $3.32 Million
Q4 2023

Dec 26, 2024
SELL
$14.28 - $31.03 $1.59 Million - $3.45 Million
-111,158 Reduced 56.26%
86,425 $2.56 Million
Q4 2023

Feb 12, 2024
SELL
$14.28 - $31.03 $1.04 Million - $2.26 Million
-72,993 Reduced 45.79%
86,425 $2.56 Million
Q3 2023

Nov 14, 2023
SELL
$19.33 - $36.22 $797,033 - $1.49 Million
-41,233 Reduced 20.55%
159,418 $3.31 Million
Q2 2023

Aug 11, 2023
BUY
$24.18 - $42.46 $1.37 Million - $2.4 Million
56,565 Added 39.26%
200,651 $4.92 Million
Q1 2023

May 18, 2023
BUY
$35.86 - $46.5 $1.29 Million - $1.67 Million
35,942 Added 33.24%
144,086 $5.85 Million
Q1 2023

May 11, 2023
SELL
$35.86 - $46.5 $3.35 Million - $4.35 Million
-93,554 Reduced 46.38%
108,144 $4.39 Million
Q4 2022

Feb 13, 2023
BUY
$35.49 - $56.15 $1.44 Million - $2.29 Million
40,695 Added 25.28%
201,698 $9.07 Million
Q3 2022

Nov 14, 2022
BUY
$43.76 - $68.97 $690,489 - $1.09 Million
15,779 Added 10.87%
161,003 $7.7 Million
Q2 2022

Aug 11, 2022
BUY
$53.22 - $123.09 $629,432 - $1.46 Million
11,827 Added 8.87%
145,224 $8.6 Million
Q1 2022

May 11, 2022
BUY
$101.89 - $150.09 $3.92 Million - $5.77 Million
38,460 Added 40.51%
133,397 $15.5 Million
Q4 2021

Feb 10, 2022
SELL
$118.18 - $153.21 $6.36 Million - $8.24 Million
-53,806 Reduced 36.17%
94,937 $14.3 Million
Q3 2021

Nov 12, 2021
BUY
$93.51 - $129.4 $13.9 Million - $19.2 Million
148,743 New
148,743 $17.8 Million

Others Institutions Holding TNDM

# of Institutions
357
Shares Held
74.6M
Call Options Held
3.3M
Put Options Held
229K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.11B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email